Perrigo Company PLC (PRGO)

Currency in USD
12.79
-0.14(-1.12%)
Real-time Data·
High dividend Yield
PRGO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
12.5812.87
52 wk Range
12.1730.93
Key Statistics
Prev. Close
13.22
Open
12.8
Day's Range
12.58-12.87
52 wk Range
12.17-30.93
Volume
1.18M
Average Volume (3m)
3.2M
1-Year Change
-56.0172%
Book Value / Share
21.33
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PRGO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
17.00
Upside
+32.92%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 23 consecutive years

Perrigo Company PLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Perrigo Company PLC Company Profile

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women’s health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Employees
8100

Perrigo Company PLC SWOT Analysis


Opill's Impact
Explore how Perrigo's OTC oral contraceptive launch could boost EPS by 10-11%, potentially transforming the company's financial landscape
Financial Outlook
Delve into Perrigo's projected sales of $4,594M for FY2024 and $4,855M for FY2025, with adjusted EPS estimates of $2.57 and $3.37 respectively
Market Positioning
Learn about Perrigo's strong foothold in the OTC private label market, benefiting from consumer trends favoring affordable self-care products
Analyst Perspectives
Discover why analysts maintain a positive outlook, with price targets ranging from $35 to $42, highlighting Perrigo's potential as a free cash flow generato
Read full SWOT analysis

Perrigo Company PLC Earnings Call Summary for Q4/2025

  • Perrigo Q4 2025 EPS of $0.77 missed forecast of $0.79 by 2.53%; revenue beat expectations at $1.11B, up $10M from estimates.
  • Stock plunged 9.65% in pre-market to $13.02, extending yearly decline to 39% amid investor concerns over earnings miss and market challenges.
  • Infant formula sales declined significantly; OTC category weakness pressured results while CORE operations showed relative resilience.
  • Q1 2026 EPS guidance set at $0.53; company focuses on strengthening CORE operations and operational efficiency amid market headwinds.
  • CEO Murray Kessler emphasized strategic initiatives for growth; company maintains 8.05% dividend yield with 23 consecutive years of increases.
Last Updated: 02/26/2026, 10:48 PM
Read Full Transcript

Compare PRGO to Peers and Sector

Metrics to compare
PRGO
Peers
Sector
Relationship
P/E Ratio
−1.3x−4.9x−0.5x
PEG Ratio
0.000.290.00
Price/Book
0.6x1.4x2.6x
Price / LTM Sales
0.4x1.2x3.3x
Upside (Analyst Target)
24.8%17.8%45.5%
Fair Value Upside
Unlock24.5%5.7%Unlock

Analyst Ratings

2 Buy
3 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 17.00
(+32.92% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
JPMorgan
Hold15.00+17.92%18.00MaintainFeb 27, 2026
Canaccord
Buy17.00+33.65%20.00MaintainFeb 27, 2026
Jefferies
Hold18.00+41.51%-MaintainFeb 26, 2026
JPMorgan
Hold18.00+41.51%20.00MaintainDec 15, 2025
Canaccord Genuity
Buy20.00+57.23%40.00MaintainNov 06, 2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -10.29%
Dividend Yield
8.77%
Industry Median 2.29%
Annualized payout
1.16
Paid quarterly
5-Years Growth
+5.21%
Growth Streak

Earnings

Latest Release
Feb 26, 2026
EPS / Forecast
0.77 / 0.79
Revenue / Forecast
1.11B / 1.10B
EPS Revisions
Last 90 days

PRGO Income Statement

People Also Watch

214.97
ONTO
-0.43%
9.71
FLO
-1.72%
293.44
UNH
+0.06%
607.86
SNDK
-4.33%
23.72
RHI
-2.87%

FAQ

What Is the Perrigo (PRGO) Stock Price Today?

The Perrigo stock price today is 12.79 USD.

What Stock Exchange Does Perrigo Trade On?

Perrigo is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for Perrigo?

The stock symbol for Perrigo is "PRGO."

Does Perrigo Pay Dividends? What’s The Current Dividend Yield?

The Perrigo dividend yield is 8.77%.

What Is the Perrigo Market Cap?

As of today, Perrigo market cap is 1.75B USD.

What Is Perrigo's Earnings Per Share (TTM)?

The Perrigo EPS (TTM) is -10.29.

When Is the Next Perrigo Earnings Date?

Perrigo will release its next earnings report on May 12, 2026.

From a Technical Analysis Perspective, Is PRGO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Perrigo Stock Split?

Perrigo has split 1 times.

How Many Employees Does Perrigo Have?

Perrigo has 8100 employees.

What is the current trading status of Perrigo (PRGO)?

As of Mar 02, 2026, Perrigo (PRGO) is trading at a price of 12.79 USD, with a previous close of 13.22 USD. The stock has fluctuated within a day range of 12.58 USD to 12.87 USD, while its 52-week range spans from 12.17 USD to 30.93 USD.

What Is Perrigo (PRGO) Price Target According to Analysts?

The average 12-month price target for Perrigo is 17.00 USD, with a high estimate of 20 USD and a low estimate of 15 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +32.92% Upside potential.

What Is the PRGO After Hours Price?

PRGO's last after hours stock price is 13.40 USD, the stock has decreased by 0.18, or 1.35%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.